These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24563441)

  • 41. MiRNA-200a expression is inverse correlation with hepatocyte growth factor expression in stromal fibroblasts and its high expression predicts a good prognosis in patients with non-small cell lung cancer.
    Chen Y; Du M; Wang J; Xing P; Zhang Y; Li F; Lu X
    Oncotarget; 2016 Jul; 7(30):48432-48442. PubMed ID: 27374174
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CYFRA 21-1 and CEA are independent prognostic factors in 153 operated stage I NSCLC patients.
    Muley T; Dienemann H; Ebert W
    Anticancer Res; 2004; 24(3b):1953-6. PubMed ID: 15274383
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum hepatocyte growth factor and interleukin-6 are effective prognostic markers for non-small cell lung cancer.
    Ujiie H; Tomida M; Akiyama H; Nakajima Y; Okada D; Yoshino N; Takiguchi Y; Tanzawa H
    Anticancer Res; 2012 Aug; 32(8):3251-8. PubMed ID: 22843899
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of preoperative hemoglobin level on survival of non-small cell lung cancer patients.
    Tomita M; Shimizu T; Hara M; Ayabe T; Onitsuka T
    Anticancer Res; 2008; 28(3B):1947-50. PubMed ID: 18630486
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of the prognostic significance of cytosolic determination of CA 125 tumor-associated antigen, carcinoembryonic antigen and squamous cell carcinoma antigen in patients with nonsmall cell lung carcinoma.
    Picardo AL; Diez M; Torres A; Maestro M; Ortega D; Hernando F; Gómez A; Garcia-Asenjo J; Balibrea JL
    Cancer; 1996 Mar; 77(6):1066-72. PubMed ID: 8635125
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preoperative serum pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen level predicts postoperative distant metastasis in patients with non-small-cell lung cancer.
    Tanaka Y; Yoshimasu T; Oura S; Hirai Y; Kawago M; Ikeda M; Okamura Y
    Eur J Cardiothorac Surg; 2013 Sep; 44(3):539-43; discussion 543. PubMed ID: 23435520
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the treatment of non-small cell lung cancer with brain metastasis and the role of risk score as a survival predictor.
    Iwasaki A; Shirakusa T; Yoshinaga Y; Enatsu S; Yamamoto M
    Eur J Cardiothorac Surg; 2004 Sep; 26(3):488-93. PubMed ID: 15302040
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preoperative prognostic factors for pN2 non-small cell lung cancer.
    Tomita M; Matsuzaki Y; Shimizu T; Hara M; Ayabe T; Onitsuka T
    Ann Thorac Cardiovasc Surg; 2006 Feb; 12(1):15-20. PubMed ID: 16572069
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma hepatocyte growth factor elevation may be associated with early metastatic disease in primary lung cancer patients.
    Hosoda H; Izumi H; Tukada Y; Takagiwa J; Chiaki T; Yano M; Arai H
    Ann Thorac Cardiovasc Surg; 2012; 18(1):1-7. PubMed ID: 21959198
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors associated with recurrence in patients with curatively resected stage I-II lung cancer.
    Koo HK; Jin SM; Lee CH; Lim HJ; Yim JJ; Kim YT; Yang SC; Yoo CG; Han SK; Kim JH; Shim YS; Kim YW
    Lung Cancer; 2011 Aug; 73(2):222-9. PubMed ID: 21168237
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Survival and prognostic factors in resected cN2-pN0 non-small cell lung cancer.
    Niizeki H; Morikawa T; Okushiba S; Kondo S; Katoh H
    Ann Thorac Cardiovasc Surg; 2004 Feb; 10(1):9-13. PubMed ID: 15008692
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic significance of the combined use of preoperative platelet count and serum carcinoembryonic antigen level in non-small-cell lung cancer.
    Tomita M; Shimizu T; Ayabe T; Onitsuka T
    Gen Thorac Cardiovasc Surg; 2010 Nov; 58(11):573-6. PubMed ID: 21069496
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical significance of pleural lavage cytology for non-small cell lung cancer: is surgical resection valid for patients with positive pleural lavage cytology?
    Kawachi R; Nakazato Y; Masui K; Takei H; Koshi-ishi Y; Goya T
    Interact Cardiovasc Thorac Surg; 2009 Aug; 9(2):265-8. PubMed ID: 19429636
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer.
    Nisman B; Amir G; Lafair J; Heching N; Lyass O; Peretz T; Barak V
    Anticancer Res; 1999; 19(4C):3549-52. PubMed ID: 10629651
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A case-case study comparing the usefulness of serum trace elements (Cu, Zn and Se) and tumor markers (CEA, SCC and SLX) in non-small cell lung cancer patients.
    Oyama T; Kawamoto T; Matsuno K; Osaki T; Matsumoto A; Isse T; Nakata S; Ozaki S; Sugaya M; Yasuda M; Yamashita T; Takenoyama M; Sugio K; Yasumoto K
    Anticancer Res; 2003; 23(1B):605-12. PubMed ID: 12680155
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum carcinoembryonic antigen level and pleural lavage cytology in woman with non-small cell lung cancer.
    Tomita M; Shimizu T; Hara M; Ayabe T; Onitsuka T
    Thorac Cardiovasc Surg; 2008 Oct; 56(7):422-5. PubMed ID: 18810701
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical value of p53, c-erbB-2, CEA and CA125 regarding relapse, metastasis and death in resectable non-small cell lung cancer.
    Pollán M; Varela G; Torres A; de la Torre M; Ludeña MD; Ortega MD; Pac J; Freixenet J; Gómez G; Sebastián F; Díez M; Arrabal R; Canalís E; García-Tirado J; Arnedillo A; Rivas JJ; Minguella J; Gómez A; García M; Aragonés N; Pérez-Gómez B; López-Abente G; González-Sarmiento R; Rojas JM
    Int J Cancer; 2003 Dec; 107(5):781-90. PubMed ID: 14566828
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
    Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated preoperative CEA is associated with subclinical nodal involvement and worse survival in stage I non-small cell lung cancer: a systematic review and meta-analysis.
    Nasralla A; Lee J; Dang J; Turner S
    J Cardiothorac Surg; 2020 Oct; 15(1):318. PubMed ID: 33059696
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictive role of CEA and CYFRA 21-1 in patients with advanced-stage NSCLC treated with erlotinib.
    Fiala O; Pesek M; Finek J; Benesova L; Minarik M; Bortlicek Z; Topolcan O
    Anticancer Res; 2014 Jun; 34(6):3205-10. PubMed ID: 24922695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.